| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H28FN3O3 |
| Molecular Weight | 401.4744 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(NC(C)=O)=CC=C1OCCCN2CCN(CC2)C3=CC=CC=C3F
InChI
InChIKey=PHOCQBYGUQPMIB-UHFFFAOYSA-N
InChI=1S/C22H28FN3O3/c1-17(27)24-18-8-9-21(22(16-18)28-2)29-15-5-10-25-11-13-26(14-12-25)20-7-4-3-6-19(20)23/h3-4,6-9,16H,5,10-15H2,1-2H3,(H,24,27)
Mafoprazine is a phenylpiperazine derivative exerting postsynaptic dopamine D2 receptor blocking activity and alpha-adrenergic activity (alpha 1 receptor blocking activity and alpha 2 receptor stimulating activity). In animal models, mafoprazine demonstrated antipsychotic, aggression-inhibiting and cataleptogenic actions.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 10.7 nM [Ki] | |||
| 12.6 nM [Ki] | |||
| 101.0 nM [Ki] |
PubMed
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
